Literature DB >> 32799667

Comparing prospective headache diary and retrospective four-week headache questionnaire over 20 weeks: Secondary data analysis from a randomized controlled trial.

Vanessa E Miller1, Keturah R Faurot1, Olafur S Palssson1, Beth A MacIntosh1, Chirayath Suchindran1, Gilson Honvoh1, Susan Gaylord1, Christopher E Ramsden1, J Douglas Mann1.   

Abstract

BACKGROUND: Headache diaries and recall questionnaires are frequently used to assess headache frequency and severity in clinical and research settings.
METHODS: Using 20 weeks of data from an intervention trial with 182 participants, we evaluated concordance between an electronic headache diary administered on a daily basis and designed to capture the presence and severity of headaches on an hourly basis (the headache diary) and a recall questionnaire, with retrospective estimation of the number of headache days assessed on a monthly basis. We further examined whether the duration or severity of headaches assessed by the electronic diary impacted concordance between these two measures.
RESULTS: Over the course of four 28-day periods, people with migraine participating in a dietary intervention reported an average of 13.7 and 11.1 headache days in the headache diary and recall questionnaire, respectively.
CONCLUSION: Over time, the concordance between headache days reported in these two measures tended to increase; however, the recall questionnaire headache estimates were lower than the diary measures in all four periods. When analysis was restricted to headaches lasting 8 hours or more, the number of headache days was more closely aligned with days reported in the recall questionnaire, indicating that the accuracy of recall estimates is likely to be influenced by headache duration. Restriction of analyses to moderate-to-severe headaches did not change results as much as headache duration. The findings indicate that recall questionnaires administered on a monthly basis may underestimate headache frequency and therefore should not be used interchangeably with headache diaries.Clinical Trials.gov Identifier: NCT02012790.

Entities:  

Keywords:  Migraine; electronic diary; headache; questionnaire; recall bias; self-report

Mesh:

Year:  2020        PMID: 32799667      PMCID: PMC9060397          DOI: 10.1177/0333102420949180

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.075


  19 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Patient non-compliance with paper diaries.

Authors:  Arthur A Stone; Saul Shiffman; Joseph E Schwartz; Joan E Broderick; Michael R Hufford
Journal:  BMJ       Date:  2002-05-18

3.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

4.  Reliability of recalled self-report on headache intensity: investigation using ecological momentary assessment technique.

Authors:  H Kikuchi; K Yoshiuchi; N Miyasaka; K Ohashi; Y Yamamoto; H Kumano; T Kuboki; A Akabayashi
Journal:  Cephalalgia       Date:  2006-11       Impact factor: 6.292

5.  Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic.

Authors:  Arthur A Stone; Joseph E Schwartz; Joan E Broderick; Saul S Shiffman
Journal:  Pers Soc Psychol Bull       Date:  2005-10

6.  The accuracy of pain and fatigue items across different reporting periods.

Authors:  Joan E Broderick; Joseph E Schwartz; Gregory Vikingstad; Michelle Pribbernow; Steven Grossman; Arthur A Stone
Journal:  Pain       Date:  2008-05-01       Impact factor: 6.961

7.  How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine.

Authors:  Jeff A McKenzie; F Michael Cutrer
Journal:  Headache       Date:  2009-05       Impact factor: 5.887

8.  Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain.

Authors:  Arthur A Stone; Joan E Broderick; Saul S Shiffman; Joseph E Schwartz
Journal:  Pain       Date:  2004-01       Impact factor: 6.961

9.  A sixteen-week three-armed, randomized, controlled trial investigating clinical and biochemical effects of targeted alterations in dietary linoleic acid and n-3 EPA+DHA in adults with episodic migraine: Study protocol.

Authors:  John Douglas Mann; Keturah R Faurot; Beth MacIntosh; Olafur S Palsson; Chirayath M Suchindran; Susan Ann Gaylord; Chanee Lynch; Angela Johnston; Kristen Maiden; David A Barrow; Joseph R Hibbeln; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-11-16       Impact factor: 4.006

10.  Assessment of headache characteristics in a general adolescent population: a comparison between retrospective interviews and prospective diary recordings.

Authors:  Anne-Berit Krogh; Bo Larsson; Øyvind Salvesen; Mattias Linde
Journal:  J Headache Pain       Date:  2016-02-24       Impact factor: 7.277

View more
  3 in total

1.  A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study.

Authors:  Torsten Schröder; Gianna Kühn; Anna Kordowski; Soodeh Razeghi Jahromi; Astrid Gendolla; Stefan Evers; Charly Gaul; Diamant Thaçi; Inke Regina König; Christian Sina
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

2.  The chronobiology of migraine: a systematic review.

Authors:  Amanda Holmen Poulsen; Samaira Younis; Janu Thuraiaiyah; Messoud Ashina
Journal:  J Headache Pain       Date:  2021-07-19       Impact factor: 7.277

3.  E-diary use in clinical headache practice: A prospective observational study.

Authors:  Daphne S van Casteren; Iris E Verhagen; Irene de Boer; Simone de Vries Lentsch; Rolf Fronczek; Erik W van Zwet; Antoinette MaassenVanDenBrink; Gisela M Terwindt
Journal:  Cephalalgia       Date:  2021-05-02       Impact factor: 6.292

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.